Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions

Seung-Woon RHA; Byoung-Geol CHOI; Man-Jong BAEK; Yang-gi RYU; Hu LI; Se-Yeon CHOI; Jae-Kyeong BYUN; Ahmed MASHALY; Yoonjee PARK; Won-Young JANG; Woohyeun KIM; Jah-Yeon CHOI; Eun-Jin PARK; Jin-Oh NA; Cheol-Ung CHOI; Hong-Euy LIM; Eung-Ju KIM; Chang-Gyu PARK; Hong-Seog SEO; Dong-Joo OH.
Yonsei Medical Journal ; : 602-610, 2018.
Artículo en Inglés | WPRIM | ID: wpr-715902

Documentos relacionados

  1. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.
  2. Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions.
  3. Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions.
  4. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
  5. Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis.
  6. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
  7. Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.
  8. Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions.
  9. Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: An analysis of drug-eluting stents in Germany and Italy.
  10. Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.